These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E; Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504 [TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen". Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV; Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033 [TBL] [Abstract][Full Text] [Related]
25. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Kushner FG; Hand M; Smith SC; King SB; Anderson JL; Antman EM; Bailey SR; Bates ER; Blankenship JC; Casey DE; Green LA; Hochman JS; Jacobs AK; Krumholz HM; Morrison DA; Ornato JP; Pearle DL; Peterson ED; Sloan MA; Whitlow PL; Williams DO J Am Coll Cardiol; 2009 Dec; 54(23):2205-41. PubMed ID: 19942100 [No Abstract] [Full Text] [Related]
26. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444 [TBL] [Abstract][Full Text] [Related]
27. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI). Hamirani YS; Jibrin I; Abraham D; Merriman B; Wenz C; Bahr RD Crit Pathw Cardiol; 2008 Dec; 7(4):232-8. PubMed ID: 19050419 [TBL] [Abstract][Full Text] [Related]
28. Early management of ST-segment elevation myocardial infarction. Sura AC; Kelemen MD Cardiol Clin; 2006 Feb; 24(1):37-51. PubMed ID: 16326255 [TBL] [Abstract][Full Text] [Related]
29. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Laskey WK; Yoon S; Calzada N; Ricciardi MJ Catheter Cardiovasc Interv; 2008 Aug; 72(2):212-20. PubMed ID: 18546233 [TBL] [Abstract][Full Text] [Related]
30. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808 [TBL] [Abstract][Full Text] [Related]
31. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Antman EM; Anbe DT; Armstrong PW; Bates ER; Green LA; Hand M; Hochman JS; Krumholz HM; Kushner FG; Lamas GA; Mullany CJ; Ornato JP; Pearle DL; Sloan MA; Smith SC; Alpert JS; Anderson JL; Faxon DP; Fuster V; Gibbons RJ; Gregoratos G; Halperin JL; Hiratzka LF; Hunt SA; Jacobs AK; Circulation; 2004 Aug; 110(5):588-636. PubMed ID: 15289388 [No Abstract] [Full Text] [Related]
32. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB; Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433 [TBL] [Abstract][Full Text] [Related]
33. Drug-eluting stents in primary percutaneous coronary intervention for ST-elevation myocardial infarction: an up-to-date review of the literature. Ehdaie A; Lee MS Minerva Cardioangiol; 2009 Oct; 57(5):645-55. PubMed ID: 19838154 [TBL] [Abstract][Full Text] [Related]
34. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III. Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ; J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524 [TBL] [Abstract][Full Text] [Related]
35. Antiplatelet intervention in acute coronary syndrome. Arora RR; Rai F Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648 [TBL] [Abstract][Full Text] [Related]
36. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Antman EM; Anbe DT; Armstrong PW; Bates ER; Green LA; Hand M; Hochman JS; Krumholz HM; Kushner FG; Lamas GA; Mullany CJ; Ornato JP; Pearle DL; Sloan MA; Smith SC; ; Can J Cardiol; 2004 Aug; 20(10):977-1025. PubMed ID: 15332148 [No Abstract] [Full Text] [Related]
37. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy. Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR; Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656 [TBL] [Abstract][Full Text] [Related]
38. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE). Alexander D; Ou FS; Roe MT; Pollack CV; Ohman EM; Cannon CP; Gibler WB; Fintel DJ; Peterson ED; Brown DL; Am Heart J; 2008 Sep; 156(3):606-12. PubMed ID: 18760147 [TBL] [Abstract][Full Text] [Related]
39. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study). Terkelsen CJ; Nørgaard BL; Lassen JF; Poulsen SH; Gerdes JC; Sloth E; Gøtzsche LB; Rømer FK; Thuesen L; Nielsen TT; Andersen HR Eur Heart J; 2006 Feb; 27(3):267-75. PubMed ID: 16227311 [TBL] [Abstract][Full Text] [Related]
40. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Kaltoft A; Bøttcher M; Nielsen SS; Hansen HH; Terkelsen C; Maeng M; Kristensen J; Thuesen L; Krusell LR; Kristensen SD; Andersen HR; Lassen JF; Rasmussen K; Rehling M; Nielsen TT; Bøtker HE Circulation; 2006 Jul; 114(1):40-7. PubMed ID: 16801464 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]